Curcumin (CM) has anticancer potential for several cancers and blocks several steps in the carcinogenesis process. However, the clinical application of CM is greatly limited due to its low effects in vivo resulted from its poor solubility and pharmacokinetics. This raises the possibility of taking CM as a novel model drug in a new nanoparticlebased delivery system. In this study, CM-loaded nanoparticles were prepared from three kinds of amphilic methoxy poly(ethylene glycol) (mPEG) -polycaprolactone (PCL) block copolymers. It was noted that CM-loaded nanoparticles prepared from mPEG10k -PCL30k showed not only the highest loading efficiency, but also the most sustained release pattern. In vitro studies showed that CM was effectively transported into A549 cells by nanoparticles and localized around the nuclei in the cytoplasm. In addition, the cytotoxicity of CM-loaded nanoparticles with mEPG10k-PCL30k as a drug carrier was in a dose-and time-dependent manner in A549 cells. Further apoptotic staining results demonstrated the superior pro-apoptotic effect of CMloaded nanoparticles over free drug. Data in this study not only confirmed the potential of CM in treating lung cancer, but also offered an effective way to improve the anticancer efficiency of CM through the nano-drug delivery system.
Introduction
Lung cancer is an aggressive and progressive deadly disease with few treatment options and poor overall survival in nonsurgical stages. Despite recent advances in the treatments for other cancers, the 5-year survival rate of patients suffering from lung cancer of all stages is still only 16% [1] . Systemic chemotherapy, one of the main cancer treatment methods, has unavoidable toxicity without satisfactory treatment effect. Therefore, it is important to identify potential drugs and explore more efficient therapeutic strategies for the treatment of lung cancer.
Curcumin (CM) is a biphenyl compound in the herb Curcuma longa and possesses anti-inflammatory, anticancer, antioxidant, wound healing, and antimicrobial activities [2, 3] . CM has anticancer potential for several cancers and blocks several steps in the carcinogenesis process [4] [5] [6] [7] . Despite these extraordinary properties, CM has limited application in the treatment of cancer due to its considerable hydrophobicity, instability, and poor pharmacokinetics, which greatly hampers its efficacy in vivo [8] [9] [10] . Thus, it is desirable to explore novel formulations of CM that overcome the limitations mentioned above.
Recent progress in drug delivery studies has focused on improving the delivery system for malignant diseases by nanomedicine and polymer techniques [11] . These drug carriers have the following advantages: (i) enhancing the solubility of hydrophobic agents; (ii) releasing the antitumor agents in a sustainable pattern; and (iii) having preferable biocompatibility and biodegradability [12] [13] [14] . Polycaprolactone (PCL) was chosen as the hydrophobic segment of block copolymer because of its good drug encapsulation ability. In addition, the slow degradation of PCL-based particles allows the extended release of the drug [15] . Polyethylene glycol (PEG) possesses a number of outstanding physiochemical and biological properties. Owing to its good biocompatibility, hydrophilicity, and the absence of antigenicity and immunogenicity, the core -shell structure with PEG as an outer shell enables nanoparticles to escape from the scavenging of reticuloendothelial systems [16] .
In the present study, we prepared biodegradable methoxy poly(ethylene glycol) (mPEG)-PCL nanoparticles incorporating CM, which provides a feasible way to overcome the limitations of CM in clinical applications. The mPEG-PCL copolymers were prepared with different PEG/PCL ratios, which influenced the properties of copolymers and the effectiveness of nanoparticles. To determine which composition was most suitable for the delivery of CM, three kinds of mPEG-PCL copolymers were synthesized. In addition, we evaluated the feasibility of this mPEG-PCL system by testing its in vitro cytotoxicity against human lung cancer cell line A549.
Materials and Methods
Materials and cell culture CM, 1-caprolactone (1-CL), mPEG (2, 4, or 10 kDa) were purchased from Sigma (St Louis, USA). PEG samples were dehydrated by azeotropic distillation with toluene and vacuum-dried at 508C for 12 h before use. 1-CL was purified by drying CaH 2 at room temperature and distillation under reduced pressure. Stannous octoate, 4 0 ,6-diamidino-2-phenylindole (DAPI), and 3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma. All other chemicals were of analytical grade and used without further purification. Human lung cancer cell line A549 was obtained from the Institute of Biochemistry and Cell Biology, CAS (Shanghai, China). Cells were maintained in RPMI-1640 medium (Life Technologies, Inc., Gaithersburg, USA) containing 10% fetal bovine serum (Life Technologies, Inc.), 100 U/ml penicillin, and 100 U/ml streptomycin in a humidified atmosphere with 5% CO 2 at 378C.
Synthesis and characterization of mPEG and PCL block copolymers mPEG-PCL block copolymers were synthesized according to the methods reported previously [17] . Briefly, a predetermined amount of 1-CL was added into a polymerization tube containing mPEG and a small amount of stannous octoate (0.1%, w/w). The tube was then connected to a vacuum system, sealed off, and placed in an oil bath at 1308C for 48 h. At the end of the polymerization, the crude copolymers were dissolved with dichloromethane and precipitated into an excess amount of cold methanol to remove the un-reacted monomer and oligomer. The precipitates were then filtered and washed with water several times before being thoroughly dried at reduced pressure. Gel permeation chromatography was used to characterize the copolymers.
Preparation of CM-loaded nanoparticles CM-loaded nanoparticles were prepared by a nanoprecipitation method as described previously with minor modifications [17] . Briefly, 10 mg of each copolymer and 2 mg of CM were dissolved in 0.3 ml of hot acetone. The obtained organic solution was added dropwise into 10-time volumes of distilled water under gentle stirring at room temperature. The solution was dialyzed in a dialysis bag (molecular weight cut-off 4 kDa; Sigma) to remove acetone thoroughly. The obtained bluish aqueous solution was filtered through a 0.22-mm filter membrane to remove nonincorporated drugs and copolymer aggregates. Coumarin-6, C 20 H 18 N 2 O 2 S, is a hydrophobic dye exhibiting green fluorescence under excitation with a molecular weight of 350.43 Da. Coumarin-6-loaded nanoparticles and blank nanoparticles were produced in a similar manner without adding drugs. These prepared nanoparticles were lyophilized for further use.
Size and zeta potential analysis of nanoparticles
The mean diameter and size distribution of nanoparticles were measured by dynamic light scattering (DLS) with a Brookheaven BI9000AT system (Brookhaven Instruments Corporation, New York, USA). Zeta potential was measured by using a laser Doppler anemometry (Zeta Plus, Zeta Potential Analyzer; Brookhaven Instruments Corporation). Measurements were performed at least in triplicate.
Morphology studies
Morphological examination of nanoparticles was carried out by using a JEM-100S transmission electron microscope (TEM) (Olympus Company Ltd., Tokyo, Japan). One drop of the nanoparticle solution was negatively stained with 1% (w/v) phosphotungstic sodium solution and placed on a copper grid covered with nitrocellulose membrane.
Drug loading content and encapsulation efficiency detection of CM-loaded nanoparticles
The concentration of CM was measured by using a LC-10AD HPLC system (Shimadzu, Tokyo, Japan) equipped with a Shimadzu UV detector and an Agilent C-18 RP-HPLC analytical column (Ø 5 mm, 250 mm Â 4.6 mm). The mobile phase was composed of acetonitrile2 monosodium phosphate (10 mM, pH 3.5 adjusted by orthophosphoric acid) (50 : 50, v/v) at a flow rate of 1.0 ml/min. The run time for analysis was 27 min and the detection wavelength was set at 425 nm. Each sample injection volume was 20 ml. The drug loading content (DLC) and encapsulation efficiency (EE) were calculated by Equations (1) and (2), respectively:
Weight of the drug in nanoparticles Weight of the nanoparticles Â 100% ð1Þ
In vitro release assay of CM-loaded nanoparticles In vitro release of CM from the mPEG-PCL nanoparticles was evaluated using a dialysis bag diffusion technique after the preparation of CM-loaded nanoparticles as described previously with minor modifications [17] . Briefly, 10 mg of each kind of CM-loaded nanoparticles were suspended in 1 ml of 0.1 M phosphate-buffered saline (PBS, pH 7.4). The solution was placed into a pre-swelled dialysis bag with a 4-kDa molecular weight cut-off (Sigma) and immersed into 20 ml of 0.1 M PBS, pH 7.4, at 378C with gentle agitation. At different times, 1 ml of incubation medium was analyzed to measure CM concentration as described above. Then, the other incubation medium was immediately supplemented with 1 ml of fresh PBS to maintain the volume. The concentration of CM released from nanoparticles was expressed as a percentage of total CM in the nanoparticles and plotted as a function of time.
Cellular uptake analysis of particles
The cellular uptake analysis was carried out according to previous reports [18, 19] . Coumarin-6 was used to detect the uptake efficiency of nanoparticles by tumor cells. Cells were seeded in six-well plates at a density of 4 Â 10 4 cells per well. After incubation in a humidified atmosphere with 5% CO 2 for 24 h at 378C, cells were exposed to medium containing coumarin-6-loaded nanoparticles (12.5 mg/ml). After 2-h incubation, the cell monolayers were washed 3-4 times with PBS at 378C. Then, the cells were examined under a fluorescence microscope.
In vitro cytotoxicity assay of CM-loaded nanoparticles The half maximal inhibitory concentration (IC 50 ) of CM-loaded nanoparticles on A549 cells were determined by MTT assay. Briefly, cells were seeded in 96-well plates at 1 Â 10 4 cells per well. Twenty-four hours later, cells were exposed to a series of equivalent doses of free CM or CM-loaded nanoparticles, ranging from 20 to 70 mg/ml. After 24, 48, or 72 h, 20 ml of 5 mg/ml MTT solution was added to each well and the plate was incubated for 4 h. Then, the medium was removed and dimethylsulfoxide (150 ml) was added to each well. The optical density (OD) of each well was measured by using a microplate reader (Bio-Rad, Hercules, USA) at 560 nm. Cell viability was calculated by Equation (3):
All data obtained from MTT assay were confirmed by repeating the experiment for at least three times and by testing in triplicate each time.
DAPI staining assay
Cells were treated with blank nanoparticles (200 mM), free CM (40 mM), or CM-loaded nanoparticles (40 mM) for 48 h, washed once in PBS, and then fixed in cold methonal : acetone (1 : 1) for 5 min. After washing three times with PBS, cells were treated with 4 mg/ml DAPI for 10 min at room temperature. Cells with morphological changes of apoptosis were observed with an original magnification of Â200.
Statistical analysis
Data were expressed as the mean + SD. Student's t-test and analysis of variance were used to analyze the data. P , 0.05 was considered statistically significant.
Results
Size, zeta potential, and morphology of CM-loaded nanoparticles The particle size and size distribution of the CM-loaded nanoparticles in aqueous solution were determined by DLS and the results are displayed in Table 1 . The mean diameter of mPEG10k-PCL30k is about 140 nm, the largest among the three nanoparticles prepared. All the nanoparticles are negatively charged. The particle size and zeta potential of the blank nanoparticles were not significantly different from those of CM-loaded nanoparticles (data not shown). Figure 1 (A) shows a typical picture of the solution of CM-loaded nanoparticles ( prepared from the copolymer mPEG10k-PCL30k), which looks yellow due to the encapsulated CM. CM-loaded nanoparticles were completely dispersed in aqueous media with no aggregates and free CM exhibited poor aqueous solubility (data not shown). Figure 1(B) shows the TEM pictures of nanoparticles prepared by mPEG10k-PCL30k. It was clearly shown that the shape was nearly spherical and the size was about 120 nm in diameter.
In vitro release pattern of CM-nanoparticles All nanoparticles exhibited a fast release of CM at initial stage, and then a sustained one [ Fig. 1(C) ]. An initial burst of 35%-45% release was found at the fifth hour due to the affiliation of drug to nanoparticle surface. Afterwards, it was observed that CM was released from nanoparticles in a sustained manner. CM was released more rapidly from smaller nanoparticles. mPEG2k-PCL4k showed the most prominent burst release ( 45% at the 5th hour and 60% at the 24th hour), while the release pattern of mPEG10k-PCL30k was the most sustainable with the smallest initial burst rate ( 30% at the 5th hour and 45% at the 24th hour). Hence, CM-loaded nanoparticles formed by using mPEG10k-PCL30k were chosen for in vitro cytotoxicity assay due to its relatively higher DLC and EE and better sustained release pattern. Table 2 shows the DLC and EE of three kinds of nanoparticles. mPEG10k-PCL30k possessed the highest DLC which was detected to be 12.3% + 1.5%, as well as an EE . 80%.
DLC and EE of nanoparticles
Meanwhile, the DLCs of CM in other two kinds of nanoparticles were ,10%. All of them had an EE .75%, indicating that CM was encapsulated into mPEG-PCL nanoparticles with a relatively high DLC and EE, which might be due to the strong hydrophobic interaction between CM and PCL.
Cellular uptake studies Figure 2 shows the cellular uptake of CM-loaded nanoparticles and it was obvious that 2-h incubation was sufficient for A549 cells to uptake nanoparticles which were localized in the cytoplasm.
In vitro cytotoxicity of CM-nanoparticles
The cytotoxicity of CM-loaded particles against A549 cells was evaluated by MTT assay. Both CM and CM-loaded nanoparticles showed cytotoxicity against the cells in similar dose-and time-dependent manners (Fig. 3) . IC 50 values of free CM and CM-loaded nanoparticles are shown in Table 3 . It was obvious that CM-loaded nanoparticles, at equivalent dose, exhibited better cytotoxicity than free CM.
Apoptotic staining A549 cells were treated with a series of concentrations of blank nanoparticles, free CM, and CM-loaded nanoparticles for 48 h, respectively. DAPI staining assay showed that cells in control or blank nanoparticle group had rounded and intact nuclei (Fig. 4) , while cells treated with free CM or CM-loaded nanoparticles had nuclei that were smaller and brighter, showing crescent-shaped profiles around the periphery of the nucleus and separate globular structures (apoptotic bodies). The number of apoptotic cells treated with CM-loaded nanoparticles dramatically increased, when compared with those treated with free CM (P , 0.05). These data demonstrated that blank nanoparticles had no toxicity and that CM had an effect to induce A549 cells apoptosis. Quantitative analysis revealed that CM-loaded nanoparticles had a higher apoptosis rate, when compared with free CM [ Fig. 4(E) ].
Discussion
Plasmonic nanoparticles have received considerable attention due to their potential use in cancer diagnostics and therapeutic applications [20, 21] . In the present study, three kinds of mPEG-PCL copolymers were chosen as drug carriers. It was found that mPEG10k-PCL30k block copolymers possessed the highest drug loading efficiency and the most sustained release pattern. Fluorescent microscopy indicated that the uptake of CM by A549 cells was facilitated when delivered by nanoparticles. It was reported that the percentage of cellular uptake was influenced by the concentration of nanoparticles [22] . The cellular uptake of nanoparticles is important and mediated through endocytosis rather than passive diffusion [23] , which might be a saturable process. When the concentration of nanoparticles is beyond the uptake capacity of endocytosis, the uptake efficiency will not increase in a concentration-dependent manner [24] .
In in vitro cytotoxicity assay, CM-loaded nanoparticles led to higher cell death rates with lower IC 50 , when compared with free CM (Fig. 3) . However, at doses .80 mM, CM-loaded nanoparticles induced similar cell inhibition. These results were in accordance with previous studies [22, [25] [26] [27] . The possible mechanism is through the enhanced intracellular drug accumulation by nanoparticle uptake [28] . Data from cellular uptake experiments also confirmed the high cell affinity of nanoparticles (Fig. 2) . However, the intracellular uptake of nanoparticles by cells still has limits, which presents a potential mechanism to explain why further increases in the dose cause similar cell inhibition in cells treated with free CM or CM-loaded nanoparticles [22] . 
Curcumin-loaded nanoparticles against lung cancer
Programmed cell death is characterized by apoptotic morphology, including chromatin condensation, membrane blabbing, internucleosome degradation of DNA, and apoptotic body formation [29, 30] . In this present study, DAPI staining also demonstrated that CM-loaded nanoparticles induced more apoptosis than free CM, which was consistent with the results of cytotoxicity assay.
To enhance the targeting effect of the nano-drug system, active-targeting strategies of specific antibody conjugation with nanoparticles are under careful consideration in our lab. In our preliminary study, CM-loaded nanoparticles modified by epidermal growth factor receptor antibodies showed specific accumulation in tumor site. The current study confirmed the potential of CM in treating lung cancer and offered an effective way to improve the anticancer efficiency of CM by nano-drug delivery system. Our future research will focus on the in vivo evaluation in xenografts, which will promote the development of this system. 
